Testing gene therapy vectors in human primary nasal epithelial cultures

Molecular Therapy Methods and Clinical Development

Volumn 2, Issue , 2015, Pages 15034-

  Cao, Huibi ^a   Ouyang, Hong ^a   Ip, Wan ^a   Du, Kai ^a   Duan, Wenming ^a   Avolio, Julie ^a   Wu, Jing ^a   Duan, Cathleen ^a   Yeger, Herman ^a   Bear, Christine E ^a,b   Gonska, Tanja ^a,c   Hu, Jim ^a   Moraes, Theo J ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EGTAZIC ACID; FORSKOLIN; HELPER DEPENDENT ADENOVIRAL VECTOR; LYSOPHOSPHATIDYLCHOLINE; GREEN FLUORESCENT PROTEIN;

ARTICLE; CELL CULTURE; CILIARY MOTILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NOSE EPITHELIUM; PRIORITY JOURNAL; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE; APICAL MEMBRANE; CYSTIC FIBROSIS; EPITHELIUM CELL; GENE MUTATION; GENETIC TRANSDUCTION; HUMAN CELL CULTURE; TRANSGENE; TURBINATE; VIRAL GENE THERAPY;

EID: 85014384410     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2015.34     Document Type: Article

References (21)

1. 1 Cystic Fibrosis Foundation Patient Registry: 2012. Annual Data Report to the Center Directors, Bethesda, MD, 2013.
2. 2 Grubb, BR, Pickles, RJ, Ye, H, Yankaskas, JR, Vick, RN, Engelhardt, JF, et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371 (1994), 802–806.
3. 3 Zabner, J, Ramsey, BW, Meeker, DP, Aitken, ML, Balfour, RP, Gibson, RL, et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 97 (1996), 1504–1511.
4. 4 Zabner, J, Couture, LA, Smith, AE, Welsh, MJ, Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum Gene Ther 5 (1994), 585–593.
5. 5 Griesenbach, U, Alton, EW, Current status and future directions of gene and cell therapy for cystic fibrosis. BioDrugs 25 (2011), 77–88.
6. 6 Mueller, C, Flotte, TR, Gene therapy for cystic fibrosis. Clin Rev Allergy Immunol 35 (2008), 164–178.
7. 7 Flotte, TR, Ng, P, Dylla, DE, McCray, PB Jr, Wang, G, Kolls, JK, et al. Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis. Mol Ther 15 (2007), 229–241.
8. 8 Pickles, RJ, McCarty, D, Matsui, H, Hart, PJ, Randell, SH, Boucher, RC, Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer. J Virol 72 (1998), 6014–6023.
9. 9 Granio, O, Ashbourne Excoffon, KJ, Henning, P, Melin, P, Norez, C, Gonzalez, G, et al. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia. Hum Gene Ther 21 (2010), 251–269.
10. 10 Guo-Parke, H, Canning, P, Douglas, I, Villenave, R, Heaney, LG, Coyle, PV, et al. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 188 (2013), 842–851.
11. 11 Cao, H, Machuca, TN, Yeung, JC, Wu, J, Du, K, Duan, C, et al. Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors. Mol Ther Nucleic Acids, 2, 2013, e127.
12. 12 Cao, H, Molday, RS, Hu, J, Gene therapy: light is finally in the tunnel. Protein Cell 2 (2011), 973–989.
13. 13 Koehler, DR, Sajjan, U, Chow, YH, Martin, B, Kent, G, Tanswell, AK, et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc Natl Acad Sci USA 100 (2003), 15364–15369.
14. 14 Yan, Z, Stewart, ZA, Sinn, PL, Olsen, JC, Hu, J, McCray, PB Jr, Engelhardt, JF, Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy. Hum Gene Ther Clin Dev 26 (2015), 38–49.
15. 15 Lay, MK, González, PA, León, MA, Céspedes, PF, Bueno, SM, Riedel, CA, et al. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect 15 (2013), 230–242.
16. 16 Villenave, R, Thavagnanam, S, Sarlang, S, Parker, J, Douglas, I, Skibinski, G, et al. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci USA 109 (2012), 5040–5045.
17. 17 MacRedmond, RE, Greene, CM, Dorscheid, DR, McElvaney, NG, O'Neill, SJ, Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res, 8, 2007, 84.
18. 18 McDougall, CM, Blaylock, MG, Douglas, JG, Brooker, RJ, Helms, PJ, Walsh, GM, Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol 39 (2008), 560–568.
19. 19 Liu, X, Luo, M, Guo, C, Yan, Z, Wang, Y, Engelhardt, JF, Comparative biology of rAAV transduction in ferret, pig and human airway epithelia. Gene Ther 14 (2007), 1543–1548.
20. 20 Horani, A, Nath, A, Wasserman, MG, Huang, T, Brody, SL, Rho-associated protein kinase inhibition enhances airway epithelial Basal-cell proliferation and lentivirus transduction. Am J Respir Cell Mol Biol 49 (2013), 341–347.
21. 21 Palmer, D, Ng, P, Improved system for helper-dependent adenoviral vector production. Mol Ther 8 (2003), 846–852.